Increased soluble CD154 (CD40 Ligand) levels in xenograft recipients correlate with the development of de novo anti-pig IgG antibodies

Transplantation

Volumn 97, Issue 5, 2014, Pages 502-508

  Ezzelarab, Mohamed B ^a   Ekser, Burcin ^a,b   Isse, Kumiko ^a   Iwase, Hayato ^a   Morelli, Adrian E ^a,c   Ayares, David ^d   Cooper, David K C ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF CATANIA   (Italy)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d REVIVICOR INC   (United States)

Author keywords

CD154; Costimulation blockade; IgG antibodies; Pig; Xenotransplantation

Indexed keywords

CD20 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; KI 67 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; BABOON; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; GRAFT RECIPIENT; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE COUNT; NONHUMAN; PRIORITY JOURNAL; XENOTRANSPLANTATION;

ANIMALS; ANTIBODIES; ANTIBODIES, MONOCLONAL; ARTERIES; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CELL PROLIFERATION; GRAFT REJECTION; HETEROGRAFTS; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; LYMPH NODES; MODELS, ANIMAL; PAPIO; SWINE; TRANSPLANTATION;

EID: 84896317904     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000042     Document Type: Article

References (29)

1. Schmelzle M, Schulte Esch J 2nd, Robson SC. Coagulation, platelet activation and thrombosis in xenotransplantation. Curr Opin Organ Transplant 2010; 15: 212
2. Elzey BD, Tian J, Jensen RJ, et al. Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity 2003; 19: 9
3. Xu H, Zhang X, Mannon RB, et al. Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154. J Clin Invest 2006; 116: 769
4. Clark LB, Foy TM, Noelle RJ. CD40 and its ligand. Adv Immunol 1996; 63: 43
5. Ezzelarab MB, Ekser B, Echeverri G, et al. Costimulation blockade in pig artery patch xenotransplantationVa simple model to monitor the adaptive immune response in nonhuman primates. Xenotransplantation 2012; 19: 221
6. Lee RS, Yamada K, Womer KL, et al. Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses. J Immunol 2000; 164: 3434
7. Gray D, Siepmann K, van Essen D, et al. B-T lymphocyte interactions in the generation and survival of memory cells. Immunol Rev 1996; 150: 45
8. Castigli E, Alt FW, Davidson L, et al. CD40-deficient mice generated by recombination-Activating gene-2-deficient blastocyst complementation. Proc Natl Acad Sci U S A 1994; 91: 12135
9. Kawabe T, Naka T, Yoshida K, et al. The immune responses in CD40-deficient mice: Impaired immunoglobulin class switching and germinal center formation. Immunity 1994; 1: 167
10. Xu J, Foy TM, Laman JD, et al. Mice deficient for the CD40 ligand. Immunity 1994; 1: 423
11. Renshaw BR, Fanslow WC 3rd, Armitage RJ, et al. Humoral immune responses in CD40 ligand-deficient mice. J Exp Med 1994; 180: 1889
12. Aruffo A, Farrington M, Hollenbaugh D, et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 1993; 72: 291
13. Hermann P, Van-Kooten C, Gaillard C, et al. CD40 ligand-positive CD8+ T cell clones allow B cell growth and differentiation. Eur J Immunol 1995; 25: 2972
14. Gauchat JF, Henchoz S, Mazzei G, et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 1993; 365: 340
15. Gauchat JF, Henchoz S, Fattah D, et al. CD40 ligand is functionally expressed on human eosinophils. Eur J Immunol 1995; 25: 863
16. Pinchuk LM, Klaus SJ, Magaletti DM, et al. Functional CD40 ligand expressed by human blood dendritic cells is up-regulated by CD40 ligation. J Immunol 1996; 157: 4363
17. Grammer AC, Bergman MC, Miura Y, et al. The CD40 ligand expressed by human B cells costimulates B cell responses. J Immunol 1995; 154: 4996
18. Henn V, Slupsky JR, Grafe M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391: 591
19. Danese S, Katz JA, Saibeni S, et al. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut 2003; 52: 1435
20. Kirk AD, Morrell CN, Baldwin WM 3rd. Platelets influence vascularized organ transplants from start to finish. Am J Transplant 2009; 9: 14
21. Elzey BD, Grant JF, Sinn HW, et al. Cooperation between plateletderived CD154 and CD4+ T cells for enhanced germinal center formation. J Leukoc Biol 2005; 78: 80
22. Sprague DL, Elzey BD, Crist SA, et al. Platelet-mediated modulation of adaptive immunity: Unique delivery of CD154 signal by plateletderived membrane vesicles. Blood 2008; 111: 5028
23. Ezzelarab M, Garcia B, Azimzadeh A, et al. The innate immune response and activation of coagulation in alpha1,3-galactosyltransferase gene-knockout xenograft recipients. Transplantation 2009; 87: 805
24. Robson SC, Cooper DK, d'Apice AJ. Disordered regulation of coagulation and platelet activation in xenotransplantation. Xenotransplantation 2000; 7: 166
25. Shahinian A, Pfeffer K, Lee KP, et al. Differential T cell costimulatory requirements in CD28-deficient mice. Science 1993; 261: 609
26. Ferguson SE, Han S, Kelsoe G, et al. CD28 is required for germinal center formation. J Immunol 1996; 156: 4576
27. Larsen CP, Pearson TC, Adams AB, et al. Rational development of LEA29Y (belatacept), a high-Affinity variant of CTLA4-Ig with potent immunosuppressive properties. Am J Transplant 2005; 5: 443
28. Thompson P, Cardona K, Russell M, et al. CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates. Am J Transplant 2011; 11: 947
29. Yang Y, Wilson JM. CD40 ligand-dependent T cell activation: Requirement of B7-CD28 signaling through CD40. Science 1996; 273: 1862